Post-Discharge Management After Major Cancer Surgery
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Recruiting
Phase 3Interventional Study
SurgeryCancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Treatment
Participants needed
880 (estimated)
Sponsor
Fox Chase Cancer Center · Other
Who this trial is looking for
This trial is looking for patients who are scheduled for major cancer surgery. Participants will either receive enhanced follow-up care after surgery or standard follow-up care.
Are You a Good Fit for This Trial?
You may be able to join if
I am over 18 years old.
I have a cancer diagnosis that is either confirmed or suspected.
I am scheduled for elective major cancer surgery within 30 days.
I am able to understand and sign consent forms.
I can return for required appointments.
You may not be able to join if
I have a condition that could interfere with my participation.
I have had a recent surgery that is not listed in the study.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This is a randomized trial of intensified post-discharge surveillance (Intervention Arm) versus standard post-discharge surveillance (Control Arm).
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
First Registration Inclusion Criteria:
* Age \> 18 years at diagnosis
* ECOG performance status 0, 1, or 2, defined as
Grade ECOG 0 Fully active, able to carry on all pre-disease performance without restriction
1. Restricted in physically strenuous activity but ambulatory and able to carry out wo…
First Registration Inclusion Criteria:
* Age \> 18 years at diagnosis
* ECOG performance status 0, 1, or 2, defined as
Grade ECOG 0 Fully active, able to carry on all pre-disease performance without restriction
1. Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work
2. Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours
* Patients must have probable (i.e., clinically suspicious) or histologically/cytologically confirmed, primary or recurrent, malignant neoplasm, malignant neuroendocrine tumor, or carcinoma in situ (any stage).
Patients undergoing major operations to resect or treat known or suspected malignancies of the head and neck, chest, abdomen, genitourinary tract, or extremities are eligible. Patients undergoing biopsies, outpatient procedures, superficial resections of cutaneous malignancies, or purely palliative operations are not eligible.
These procedures are commonly performed in patients with malignant neoplasms, malignant neuroendocrine tumors, or carcinomas in situ, and are commonly "tracked" by hospitals and cancer centers participating in the ACS NSQIP Procedure Targeted option because they are often associated with higher rates of postoperative morbidity and mortality (compared to other, less complex cancer procedures).
* Patient must be scheduled for elective major cancer surgery (as listed in 4.1.4) at FCCC \< 30 days after First Registration.
Elective surgery is defined as:
* Patient is scheduled to be brought from their home (or normal living environment) to FCCC on the day of the index surgery (or day prior as scheduled admission) AND
* Surgery is not scheduled as urgent or emergent
* Ability to understand and willingness to sign a written informed consent and HIPAA consent document
* Geographical accessibility and willingness to return to FCCC for all preoperative and postoperative study assessments.
First Registration Exclusion Criteria:
* Any condition that might interfere with the subject's participation in the study, compliance with study requirements, or in the evaluation of the study results.
Second Registration Inclusion Criteria:
A patient will be eligible for continued inclusion in this study only if ALL of the following criteria apply at the time of Second Registration (one to two days prior to anticipated discharge). No exceptions or waivers will be granted for patients who do not meet the eligibility criteria.
* Post
* Elective (curative or palliative) major cancer surgery (as listed in 4.1.4 above) at the time of the index surgery (patient may have undergone more than one of these procedures) OR
* Elective surgical procedure(s) listed as an option (i.e., CPT code) in the Surgical Risk Calculator webpage (patient may have undergone more than one of these procedures)
For the purposes of this study, the procedure that was performed with the highest estimated risk of DSC (as predicted by the Surgical Risk Calculator) will be denoted at the time of Second Registration as the "index procedure" performed during the "index surgery".
* Elective surgery \< 30 days after First Registration.
Second Registration Exclusion Criteria:
* Status post elective surgical procedure(s) not listed as options in the Surgical Risk Calculator webpage. This includes patients whose scheduled procedure was suspended due to unexpected findings, such as carcinomatosis.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.